Form 4 for UTHR UNITED THERAPEUTICS Corp
Accepted 2023-01-03 00:00:00 ET · period of report 2022-12-29 · accession 0001415889-23-000056 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-03 | 2022-12-29 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $163.30 | -5,000 | 7,353 | -40% | -$816.5K |
| D | 2023-01-03 | 2022-12-29 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $275.99 | -5,000 | 2,353 | -68% | -$1.38M |
| D | 2023-01-03 | 2022-12-29 | UTHR | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $0.00 | -5,000 | 32.2K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-29 | M | D | 5,000 | $163.30 | 7,353 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-29 | S | D | 5,000 | $275.99 | 2,353 | D | — | — | |
| 3 | Derivative | Share Tracking Award | 2022-12-29 | M | D | 5,000 | $0.00 | 32,200 | D | $163.30 · 2016-03-13 to 2025-03-13 | 5,000 Common Stock | (F2) Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. |